FAPI-Conjugated Nanoparticles Show Promise for Targeted Cancer Imaging and Therapy
A systematic review finds that nanoparticles conjugated with fibroblast activation protein inhibitors show strong preclinical promise for targeted cancer imaging ...
A systematic review finds that nanoparticles conjugated with fibroblast activation protein inhibitors show strong preclinical promise for targeted cancer imaging ...
Scientists at the Italian Institute of Technology in Naples have engineered CAR-T cells with a synthetic genetic switch that activates ...
A new review in Cancer Cell International details how cancer-associated fibroblasts remodel the colorectal tumor microenvironment and drive resistance to ...
Researchers have created a chemiluminescent nanoparticle that amplifies tumor hypoxia with light, releases a chemotherapy drug in response, and glows ...
University of Sheffield researchers found that type I collagen in tumour scaffolding lets breast and pancreatic cancer cells switch fuel ...
The monk fruit, a small green gourd native to the mountainous forests of Guangxi province in southern China, has been ...
For years, CAR-T cell therapy has stood as one of cancer medicine’s most striking successes. By removing a patient’s T ...
PARP inhibitors are among the most widely used therapies for ovarian cancer, but their long-term effectiveness is limited by acquired resistance Researchers ...
A new multi-center Phase 1 study is testing casdatifan, an investigational oral therapy designed to inhibit hypoxia-inducible factor-2 alpha (HIF-2α), ...
A groundbreaking advancement in cancer treatment has emerged with the development of novel radiopharmaceutical therapies targeting fibroblast activation protein (FAP), ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine